Rockeby European patent granted for CanDia5

07-Nov-2008 - Singapore

Rockeby biomed Ltd announced that it has been granted an European Patent by the European Patent Office, with relation to CanDia5 candida assay patent.

The Patent (European Patent No. 1 381 864) relates to a method and a means of diagnosing Candida infection. In particular the present invention relates to a method of diagnosing Candida infection which is both sensitive and rapid. This further extends Rockeby’s patent coverage of its Candida diagnosis technology to the United Kingdom from countries (Australia, Japan and USA) that had previously granted patents.

Rockeby currently markets and distributes CanDia5® in Australia, New Zealand, Italy, Singapore and United Arab Emirates.

Other news from the department research and development

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy